- Home
- DSGR vs MLTX Comparison
DSGR vs MLTX Comparison
Compare DSGR & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSGR | MLTX |
|---|---|---|
| Founded | 1952 | 2021 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DSGR | MLTX |
|---|---|---|
| Price | $22.12 | $18.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $41.00 | $25.70 |
| AVG Volume (30 Days) | 89.0K | ★ 1.1M |
| Earning Date | 06-15-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 212.50 | N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $1,980,023,000.00 | N/A |
| Revenue This Year | $7.12 | N/A |
| Revenue Next Year | $4.24 | N/A |
| P/E Ratio | $121.39 | ★ N/A |
| Revenue Growth | ★ 9.75 | N/A |
| 52 Week Low | $21.27 | $5.95 |
| 52 Week High | $33.80 | $62.75 |
Technical Indicators
Market Signals| Indicator | DSGR | MLTX |
|---|---|---|
| Relative Strength Index (RSI) | 16.59 | 58.83 |
| Support Level | N/A | $14.84 |
| Resistance Level | $28.80 | $19.15 |
| Average True Range (ATR) | 1.16 | 1.02 |
| MACD | -0.89 | -0.05 |
| Stochastic Oscillator | 8.50 | 58.76 |
Price Performance
Historical ComparisonAbout DSGR Distribution Solutions Group Inc.
Distribution Solutions Group Inc is an industrial distributor of maintenance and repair supplies. It has three operating segments namely Lawson, TestEquity, and Gexpro Services, of which key revenue is derived from the TestEquity segment. The TestEquity segment is a distributor of test and measurement equipment and solutions, electronic production supplies, and tool kits from its manufacturer partners supporting the technology, aerospace, defense, automotive, electronics, education and medical industries.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.